Content about Federal Trade Commission

April 11, 2012

A federal judge in Pittsburgh will rule "later" on whether to block or allow a merger between pharmacy benefit managers Medco Health Solutions and Express Scripts, and is considering a request by two trade groups seeking to keep Medco's operations and assets separate from ESI while the lawsuit is pending, according to published reports.

NEW YORK — A federal judge in Pittsburgh will rule "later" on whether to block or allow a merger between pharmacy benefit managers Medco Health Solutions and Express Scripts, and is considering a request by two trade groups seeking to keep Medco's operations and assets separate from ESI while the lawsuit is pending, according to published reports.

April 10, 2012

Pharmacies hoping to block the merger between pharmacy benefit managers Express Scripts and Medco Health Solutions got their day in court Tuesday, according to published reports.

NEW YORK — Pharmacies hoping to block the merger between pharmacy benefit managers Express Scripts and Medco Health Solutions got their day in court Tuesday, according to published reports.

Bloomberg reported that a hearing in the U.S. District Court for the Western District of Pennsylvania began in Pittsburgh, with the National Association of Chain Drug Stores, the National Community Pharmacists Association and several independent pharmacies hoping to stop the $29.1 billion merger, which the Federal Trade Commission approved last week.

April 9, 2012

The National Advertising Division of the Council of Better Business Bureaus on Monday referred advertising for Serranol dietary supplement, marketed by Good Health Naturally, to the Federal Trade Commission for further review, after the company declined to fully participate in a National Advertising Division review of its advertising claims.

NEW YORK — The National Advertising Division of the Council of Better Business Bureaus on Monday referred advertising for Serranol dietary supplement, marketed by Good Health Naturally, to the Federal Trade Commission for further review after the company declined to fully participate in a National Advertising Division review of its advertising claims.

April 6, 2012

You can't uncrack an egg. That's the preliminary reply Express Scripts gave to the district court hearing the case filed by the National Association of Chain Drug Stores and the National Community Pharmacist Association to block the merger between Express Scripts and Medco.

WHAT IT MEANS AND WHY IT'S IMPORTANT — You can't uncrack an egg. That's the preliminary reply Express Scripts gave to the district court hearing the case filed by the National Association of Chain Drug Stores and the National Community Pharmacist Association to block the merger between Express Scripts and Medco. The pharmacy industry's concern, however, revolves around what kind of beast will hatch from this ESI-Medco merger if that cracked egg isn't unscrambled.

April 5, 2012

Teva is the first company to file for a generic version of a drug to treat sleep disorders, the Food and Drug Administration has determined.

JERUSALEM — Teva is the first company to file for a generic version of a drug used to treat sleep disorders, the Food and Drug Administration has determined, though Mylan is contesting the FDA decision.

April 2, 2012

“Straight over the cliff.” That may be the destination for many independent pharmacies now that the Federal Trade Commission has unconditionally approved the controversial merger of the nation’s second- and third-largest pharmacy benefit managers, a top pharmacy leader warned.

“Straight over the cliff.”

That may be the destination for many independent pharmacies now that the Federal Trade Commission unconditionally has approved the controversial merger of the nation’s second- and third-largest pharmacy benefit managers, a top pharmacy leader warned.

April 2, 2012

The National Association of Chain Drug Stores and the National Community Pharmacists Association announced their intent to file an additional motion requesting that the judge direct Express Scripts and Medco to keep separate their assets pending review of the lawsuit and/or schedule an expedited review of the merits of a case the two associations filed in district court last week.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores and the National Community Pharmacists Association on Monday afternoon announced their intent to file an additional motion requesting that the judge direct Express Scripts and Medco to keep separate their assets pending review of the lawsuit and/or schedule an expedited review of the merits of a case the two associations filed in district court last week.

April 2, 2012

The controversial merger between Express Scripts and Medco was completed Monday morning, according to a press release issued by both Express Scripts and the Federal Trade Commission.

WASHINGTON — The controversial merger between Express Scripts and Medco was completed Monday morning, according to a press release issued by both Express Scripts and the Federal Trade Commission.

March 30, 2012

When Express Scripts filed with the Securities & Exchange Commission that its merger with Medco could close as early as the week of April 2, that seemed to set off a firestorm of activity.

WHAT IT MEANS AND WHY IT'S IMPORTANT — When Express Scripts filed with the Securities & Exchange Commission that its merger with Medco could close as early as the week of April 2, that seemed to set off a firestorm of activity. Reports were published suggesting the Federal Trade Commission decision was imminent, and what's more that the agency would decide in favor of the merger. Speculative day traders Wednesday morning pushed the opening stock prices across both Express Scripts and Medco higher by 3.9% and 5%, respectively.

March 29, 2012

The U.S. House Judiciary Committee's Subcommittee on Intellectual Property, Competition and the Internet on Thursday morning heard testimony regarding H.R. 1946, "Preserving Our Hometown Independent Pharmacies Act of 2011."

WASHINGTON — The House Judiciary Committee's Subcommittee on Intellectual Property, Competition and the Internet on Thursday morning heard testimony regarding H.R. 1946, "Preserving Our Hometown Independent Pharmacies Act of 2011." Originally introduced by Reps. Tom Marino, R-Pa., and Louie Gahmert, R-Texas, the bill is intended to exempt independent pharmacists from antitrust regulation in an effort to bolster their negotiating powers with pharmacy benefit managers.

March 29, 2012

With as much as two-thirds of retail pharmacy operators' business tied up in the potential Express Scripts-Medco merger, the National Association of Chain Drug Stores, the National Community Pharmacists Association and nine retail pharmacy companies on Thursday filed a lawsuit challenging the merger.

ALEXANDRIA, Va. — With as much as two-thirds of retail pharmacy operators' business tied up in the potential Express Scripts-Medco merger, the National Association of Chain Drug Stores, the National Community Pharmacists Association and nine retail pharmacy companies on Thursday filed a lawsuit challenging the merger.

March 28, 2012

The Preserve Community Pharmacy Access NOW! coalition — formed in opposition of the proposed Express Scripts-Medco merger — Wednesday afternoon hosted a press conference making a direct appeal to attorneys general to block the ESI-Medco merger in the courts should the Federal Trade Commission approve the merger.

WASHINGTON — The Preserve Community Pharmacy Access NOW! coalition — formed in opposition of the proposed Express Scripts-Medco merger — Wednesday afternoon hosted a press conference making a direct appeal to attorneys general to block the ESI-Medco merger in the courts should the Federal Trade Commission approve the merger.

March 28, 2012

The Federal Trade Commission's ruling on the Express Scripts and Medco merger may be imminent, Express Scripts noted in a Form 8-K filing to the Securities and Exchange Commission on Wednesday.

ST. LOUIS — The Federal Trade Commission's ruling on the Express Scripts and Medco merger may be imminent, Express Scripts noted in a Form 8-K filing to the Securities and Exchange Commission on Wednesday.

March 27, 2012

On the eve of a potential Federal Trade Commission approval of the Express Scripts-Medco merger, Walgreens' underlying fundamentals still are strong, Walgreens president and CEO Greg Wasson told analysts Tuesday.

DEERFIELD, Ill. — On the eve of a potential Federal Trade Commission approval of the Express Scripts-Medco merger, Walgreens' underlying fundamentals still are strong, Walgreens president and CEO Greg Wasson told analysts Tuesday morning. It's that underlying strength that has helped Walgreens in the wake of its exit from the Express Scripts pharmacy benefit network, a factor that impacted Walgreens' net earnings by 7 cents per diluted share for its second quarter ended Feb. 29.

March 23, 2012

This is a critical time for the industry as the Federal Trade Commission is expected to decide the fate of the Express Scripts-Medco merger in the coming weeks. ESI-Medco, and the pharmacy benefit manager threat in general, were at the top of the list of what members of the National Association of Chain Drug Stores came to talk about at the organization's annual NACDS RxImpact Day, as chains asked lawmkers to support new legislation that would bring greater transparency to PBM bookkeeping and to tell the FTC to block ESI-Medco.

WHAT IT MEANS AND WHY IT'S IMPORTANT — This is a critical time for the industry as the Federal Trade Commission is expected to decide the fate of the Express Scripts-Medco merger in the coming weeks. ESI-Medco, and the pharmacy benefit manager threat in general, were at the top of the list of what members of the National Association of Chain Drug Stores came to talk about at the organization's annual NACDS RxImpact Day, as chains asked lawmkers to support new legislation that would bring greater transparency to PBM bookkeeping and to tell the FTC to block ESI-Medco.

March 13, 2012

The National Association of Chain Drug Stores is heading to Capitol Hill next week for its RxImpact Day event, during which it will press its case against the proposed ESI-Medco merger.

WASHINGTON — The National Association of Chain Drug Stores is heading to Capitol Hill next week for its RxImpact Day event, during which it will press its case against the proposed ESI-Medco merger.

“No issues are higher on NACDS’ list of priorities than urging members of Congress to express to the Federal Trade Commission their concerns and opposition to the proposed Express Scripts and Medco merger, and advocating for legislation to regulate pharmacy benefit managers,” stated NACDS president and CEO Steve Anderson.

February 21, 2012

Rep. Louise Slaughter, D-N.Y., has expressed concerns about the proposed merger between pharmacy benefit managers Express Scripts and Medco in a letter to the Federal Trade Commission.

WASHINGTON — Rep. Louise Slaughter, D-N.Y., has expressed concerns about the proposed merger between pharmacy benefit managers Express Scripts and Medco in a letter to the Federal Trade Commission.

The letter, dated Feb. 6, outlines how Slaughter represents a district that contains 34 independent pharmacies — which employ 364 full-time individuals — that fill more than two million prescriptions every year.

February 17, 2012

Multibillion-dollar pharmacy benefit management companies are advertising aggressively to try to convince Congress and the Federal Trade Commission to approve a merger between Express Scripts and Medco Health Solutions

Multibillion-dollar pharmacy benefit management companies are advertising aggressively to try to convince Congress and the Federal Trade Commission to approve a merger between Express Scripts and Medco Health Solutions (“PCMA launches advertising campaign,Drug Store News, Jan. 17).

February 13, 2012
Multibillion-dollar pharmacy benefit management companies are advertising aggressively to try to convince Congress and the Federal Trade Commission to approve a merger between Express Scripts and Medco Health Solution.

Multibillion-dollar pharmacy benefit management companies are advertising aggressively to try to convince Congress and the Federal Trade Commission to approve a merger between Express Scripts and Medco Health Solutions (“PCMA launches advertising campaign,” Drug Store News, Jan. 17).

February 10, 2012

With the clock ticking on the Express Scripts-Medco deal and amped up messaging coming out of the PBM lobby, NACDS vows to roll up its sleeves and make a fist.

WHAT IT MEANS AND WHY IT'S IMPORTANT — With the clock ticking on the Express Scripts-Medco deal and amped up messaging coming out of the PBM lobby, NACDS vows to roll up its sleeves and make a fist.

(THE NEWS: NACDS lays down gauntlet against PBM lobby at Regional Chain Conference. For the full story, click here)

February 10, 2012

Bloomberg on Friday reported that Express Scripts intends to inform the Federal Trade Commission that the company has delivered all the data requested regarding its purchase of Medco Health Solutions on Friday, which will trigger a 30-day period for a decision from the FTC.

NEW YORK — Bloomberg on Friday reported that Express Scripts intends to inform the Federal Trade Commission that the company has delivered all the data requested regarding its purchase of Medco Health Solutions on Friday, which will trigger a 30-day period for a decision from the FTC.

Express Scripts declined to comment for the story, Bloomberg added.

February 10, 2012

The regulatory review of the Express Scripts-Medco merger now is in its final stages, and with the clock ticking down to that 30-day deadline, you can expect a full court-press from retail pharmacy interests looking to block the deal.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The regulatory review of the Express Scripts-Medco merger now is in its final stages, and with the clock ticking down to that 30-day deadline, you can expect a full court-press from retail pharmacy interests looking to block the deal. The time for the three-point finesse shots from the corners of the court has passed, it's now time to charge the net and jam the message home; an Express Scripts-Medco merger is bad both for the retail pharmacy business and for consumers. However, it just might be good for CVS Caremark.

January 20, 2012

It has become a perennial issue, and one that is likely to crop up at least once this year: patent settlements.


It has become a perennial issue, and one that is likely to crop up at least once this year: patent settlements.


January 12, 2012

CVS Caremark announced on Thursday that the Federal Trade Commission has concluded its investigation into the company’s business practices.

WOONSOCKET, R.I. — CVS Caremark announced on Thursday that the Federal Trade Commission has concluded its investigation into the company’s business practices.

January 10, 2012

A coalition of consumer groups on Tuesday joined its collective voice to the number of constituents opposing the Express Scripts-Medco merger in a letter to the Federal Trade Commission, according to a report filed by Reuters.

WASHINGTON — A coalition of consumer groups on Tuesday joined its collective voice to the number of constituents opposing the Express Scripts-Medco merger in a letter to the Federal Trade Commission, according to a report filed by Reuters.